Another “Winter crisis” on horizon for NHS without urgent action
August 8, 2022Sales and Marketing
The NHS in England could face “very serious challenges coming down the track” without significant action tackling the emergency crisis …
SIGA will seek FDA approval of monkeypox treatment once data is available
August 8, 2022Sales and Marketing
The CEO of SIGA Technologies has announced that they are planning to ask the FDA for approval and authorisation for …
Melanoma cells use ‘molecular drills’ to invade new tissues, research finds
August 8, 2022Sales and Marketing
Scientists have identified a nerve cell gene that enables melanoma cells to branch out and invade new tissues. Research from …
F2G announce development and commercialisation for rare antifungal treatment
August 5, 2022Medical Communications
F2G, a clinical-stage biopharmaceutical company, has announced that it can now soon bring a fourth antifungal class to the market. …
Societal CDMO wins tech transfer and production contract for HIV drug candidate
August 5, 2022Medical Communications
Societal CDMO, a contract development and manufacturing organisation (CDMO) has been selected to provide CDMO services to support the ongoing …
Over 100,000 monkeypox vaccines procured, according to government
August 4, 2022Business Services
Over 100,000 doses of the monkeypox vaccine have been acquired in order to combat the spread of the virus, the …
UK health officials identify new symptoms of monkeypox
August 4, 2022Business Services
Health officials have identified a number of new monkeypox symptoms following the news that the outbreak was now a “public …
Medics in Ukraine work amid shelling and worsening health crisis
August 4, 2022Business Services
Ukraine’s health emergency is worsening WHO have shared, as the conflict with Russia continues, and staff face burnout and increased …
NHS screening pilot for Hepatitis C
August 4, 2022Business Services
Thousands will receive potentially life-saving treatment for Hepatitis C from the NHS, under a screening pilot. This is part of …
Fourth and oldest patient to be cured of HIV
July 28, 2022Business Services
A 66 year old man has become the fourth person to be effectively cured of HIV infection following a stem …
Global monkeypox cases rise to 18,000
July 28, 2022Business Services
WHO have shared that the window to stop the spread of monkeypox is closing, with cases currently doubling every two …
PCI Pharma Services announces multi-million dollar expansion to UK manufacturing facility
July 27, 2022Research and Development
PCI has announced a significant expansion of its facility in Tredegar, Wales, UK, designed to help keep up to date …
Micronesia’s first COVID outbreak sees steep rise in cases
July 27, 2022Research and Development
Micronesia’s first outbreak of COVID-19 has grown in one week to over 1,000 cases, causing significant alarm in the Pacific …
Updated NICE pre-eclampsia guidance
July 27, 2022Research and Development
New NICE guidance has been released, recommending the routine use of placental growth factor (PIGF), based on testing in the …
MHRA grant marketing authorisation for sickle cell anaemia treatment
July 26, 2022Manufacturing and Production
Global Blood Therapeutics (GBT) has announced the MHRA marketing authorisation for Oxbryta® (voxelotor) for the treatment of haemolytic anaemia due …
HealthTrackRx develops monkeypox-specific PCR test with next-day results
July 26, 2022Manufacturing and Production
HealthTrackRx is now offering a molecular test for detection of the human monkeypox virus. The test was developed by the …
Shift in drinking patterns could lead to 150,000 more cases of disease in England
July 26, 2022Manufacturing and Production
New modelling research carried out by the Institute of Alcohol Studies (IAS) and Health Lumen, has found that if alcohol …
CHMP issues positive recommendation to first and only biologic for asthma patients
July 26, 2022Manufacturing and Production
AstraZeneca’s Tezspire (tezepelumab) has been recommended for marketing authorisation in the EU, as an add-on therapy in patients 12 years …
VistaGen’s social anxiety disorder treatment fails to meet primary endpoint in Phase III
July 25, 2022Sales and Marketing
VistaGen Therapeutics has announced topline data from its Phase III PALISADE-1 trial which shows that PH94B, its nasal spray candidate …
Recent hepatitis linked to adeno-associated virus AAV2
July 25, 2022Sales and Marketing
Recent acute hepatitis cases of unknown origin in children have now been linked to the virus AAV2 in two new …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
